These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 20162273)

  • 1. Recombinant human bone morphogenetic protein 2-induced heterotopic ossification of the retroperitoneum, psoas muscle, pelvis and abdominal wall following lumbar spinal fusion.
    Shah RK; Moncayo VM; Smitson RD; Pierre-Jerome C; Terk MR
    Skeletal Radiol; 2010 May; 39(5):501-4. PubMed ID: 20162273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic heterotopic bone formation after rhBMP-2 utilization in lateral lumbar interbody fusion.
    Aichmair A; Girardi FP; Hughes AP; Sama AA; Lebl DR; Cammisa FP
    Spine J; 2013 Oct; 13(10):1411-2. PubMed ID: 24139750
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: a case report.
    Anderson CL; Whitaker MC
    Spine (Phila Pa 1976); 2012 Apr; 37(8):E502-6. PubMed ID: 22020605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic bone formation with joint impingement after posterior lumbar fusion with rhBMP-2.
    Bannwarth M; Kleiber JC; Marlier B; Eap C; Duntze J; Litre CF
    Orthop Traumatol Surg Res; 2016 Apr; 102(2):255-6. PubMed ID: 26947733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion.
    Chen NF; Smith ZA; Stiner E; Armin S; Sheikh H; Khoo LT
    J Neurosurg Spine; 2010 Jan; 12(1):40-6. PubMed ID: 20043763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroforaminal chondrocyte metaplasia and clustering associated with recombinant bone morphogenetic protein-2 usage in transforaminal lumbar interbody fusion.
    Christensen TJ; Annis P; Hohl JB; Patel AA
    Spine J; 2014 Jun; 14(6):e23-8. PubMed ID: 24291359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates.
    Wang M; Abbah SA; Hu T; Toh SY; Lam RW; Goh JC; Wong HK
    Spine (Phila Pa 1976); 2013 Aug; 38(17):1452-8. PubMed ID: 23380826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brower RS, Vickrov NM. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008;33:E653-55.
    Dickerman RD; Reynolds AS; Bennett M
    Spine (Phila Pa 1976); 2009 Apr; 34(7):749; author reply 749. PubMed ID: 19333110
    [No Abstract]   [Full Text] [Related]  

  • 9. Symptomatic ectopic intracanal ossification after transforaminal lumbar interbody fusion with rhBMP-2.
    Lehman RA; Kang DG
    Spine J; 2012 Jun; 12(6):530-1. PubMed ID: 22682741
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5.
    Brower RS; Vickroy NM
    Spine (Phila Pa 1976); 2008 Aug; 33(18):E653-5. PubMed ID: 18708918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterotopic ossification following single-level anterior cervical discectomy and fusion: results from the prospective, multicenter, historically controlled trial comparing allograft to an optimized dose of rhBMP-2.
    Arnold PM; Anderson KK; Selim A; Dryer RF; Kenneth Burkus J
    J Neurosurg Spine; 2016 Sep; 25(3):292-302. PubMed ID: 27129045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis.
    Joseph V; Rampersaud YR
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2885-90. PubMed ID: 18246013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-Pedicle Heterotopic Ossification From Use of Recombinant Human Bone Morphogenetic Protein 2 (rhBMP-2) in Transforaminal Lumbar Interbody Fusion Cages.
    Rosen CD; Kiester PD; Lee TQ
    Am J Orthop (Belle Mead NJ); 2018 Jan; 47(1):. PubMed ID: 29447305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth.
    Deutsch H
    Spine J; 2010 Feb; 10(2):e1-4. PubMed ID: 20006558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases.
    Balseiro S; Nottmeier EW
    Spine J; 2010 Jul; 10(7):e6-e10. PubMed ID: 20488766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of polyetheretherketone spacer and recombinant human bone morphogenetic protein-2 in the cervical spine: a radiographic analysis.
    Klimo P; Peelle MW
    Spine J; 2009 Dec; 9(12):959-66. PubMed ID: 19574105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ectopic bone.
    Traynelis VC
    J Neurosurg Spine; 2010 Jan; 12(1):39. PubMed ID: 20043762
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant human bone morphogenetic protein-2-induced ossification of the ligamentum flavum in rats and the associated global modification of histone H3.
    Hou XF; Fan DW; Sun CG; Chen ZQ
    J Neurosurg Spine; 2014 Sep; 21(3):334-41. PubMed ID: 24949905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotopic ossification related to the use of recombinant human BMP-2 in osteonecrosis of femoral head.
    Shi L; Sun W; Gao F; Cheng L; Li Z
    Medicine (Baltimore); 2017 Jul; 96(27):e7413. PubMed ID: 28682898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2--but what is the cost?
    Mannion RJ; Nowitzke AM; Wood MJ
    Spine J; 2011 Jun; 11(6):527-33. PubMed ID: 20739225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.